Two Sigma Investments’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$289K Sell
317,977
-162,446
-34% -$147K ﹤0.01% 2759
2025
Q1
$217K Buy
480,423
+178,879
+59% +$80.8K ﹤0.01% 2768
2024
Q4
$152K Buy
+301,544
New +$152K ﹤0.01% 2849
2023
Q3
Sell
-81,816
Closed -$115K 3016
2023
Q2
$115K Buy
81,816
+56,510
+223% +$79.7K ﹤0.01% 2654
2023
Q1
$38K Sell
25,306
-5,356
-17% -$8.03K ﹤0.01% 2712
2022
Q4
$35.9K Buy
+30,662
New +$35.9K ﹤0.01% 2568
2022
Q1
Sell
-540,824
Closed -$1.33M 2848
2021
Q4
$1.33M Sell
540,824
-39,964
-7% -$97.9K ﹤0.01% 1523
2021
Q3
$1.46M Sell
580,788
-733,779
-56% -$1.85M ﹤0.01% 1516
2021
Q2
$3.75M Buy
1,314,567
+60,036
+5% +$171K 0.01% 1037
2021
Q1
$2.95M Buy
1,254,531
+707,316
+129% +$1.66M 0.01% 1070
2020
Q4
$963K Buy
547,215
+337,210
+161% +$593K ﹤0.01% 1362
2020
Q3
$197K Sell
210,005
-118,936
-36% -$112K ﹤0.01% 1681
2020
Q2
$286K Buy
328,941
+166,308
+102% +$145K ﹤0.01% 1629
2020
Q1
$135K Sell
162,633
-191,072
-54% -$159K ﹤0.01% 1686
2019
Q4
$315K Buy
353,705
+20,610
+6% +$18.4K ﹤0.01% 1856
2019
Q3
$326K Sell
333,095
-32,345
-9% -$31.7K ﹤0.01% 1612
2019
Q2
$402K Sell
365,440
-80,134
-18% -$88.2K ﹤0.01% 1664
2019
Q1
$584K Sell
445,574
-84,403
-16% -$111K ﹤0.01% 1601
2018
Q4
$484K Buy
529,977
+364,401
+220% +$333K ﹤0.01% 1591
2018
Q3
$340K Sell
165,576
-37,419
-18% -$76.8K ﹤0.01% 1713
2018
Q2
$366K Buy
202,995
+73,230
+56% +$132K ﹤0.01% 1719
2018
Q1
$305K Sell
129,765
-200,836
-61% -$472K ﹤0.01% 1730
2017
Q4
$622K Buy
330,601
+182,218
+123% +$343K ﹤0.01% 1670
2017
Q3
$369K Sell
148,383
-9,302
-6% -$23.1K ﹤0.01% 1638
2017
Q2
$435K Buy
+157,685
New +$435K ﹤0.01% 1676
2017
Q1
Sell
-75,592
Closed -$239K 2286
2016
Q4
$239K Buy
75,592
+35,150
+87% +$111K ﹤0.01% 1986
2016
Q3
$138K Buy
+40,442
New +$138K ﹤0.01% 1952
2015
Q3
Sell
-79,122
Closed -$232K 1874
2015
Q2
$232K Buy
+79,122
New +$232K ﹤0.01% 1983